ArticleChemistry & biodiversity2026
Component Analysis Based on UHPLC-Q-Exactive-Orbitrap/MS and Immune Regulatory Activity Assessment by an LPS-Stimulated Macrophages Model of Sacha Inchi Shell (Plukenetia volubilis Linneo) Extract.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Sacha Inchi shell (SIS) is the fruit shell of Sacha Inchi (SI), a perennial woody vine belonging to the Euphorbiaceae family and native to the Amazon tropical rainforest region. Due to its various pharmacological effects such as antioxidant, anti-inflammatory, and immune modulation, it has also attracted the attention of numerous scholars. We characterized and identified the Sacha Inchi shell water extract (SISWE) using UHPLC-Q-Exactive-Orbitrap/MS technology. A total of 44 compounds were identified, which 30 components were detected in SISWE for the first time. We investigated the anti-inflammatory and immunomodulatory effects of SISWE via using the normal RAW264.7 macrophage model and LPS-induced inflammatory macrophage model. The research results indicated that SISWE enhanced the immune response by promoting the phagocytic ability, production of NO, TNF-α, and IL-6 in normal RAW264.7 cells, suppressed the excessive release of NO, IL-6, and TNF-α in LPS stimulated RAW264.7 cells, decreased the expression level of iNOS protein, and markedly inhibited the phosphorylation of p65, ERK, and JNK, demonstrating good immune regulatory effects. In this study, we demonstrated the bidirectional immunomodulatory function of SISWE. These findings highlight the therapeutic potential of SISWE for both immunodeficiency-related diseases and immune hyperactivation-related disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.